CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

BioMarin (BMRN) Financial Analysis | CapyFin

BioMarin

BMRN · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: $747M

Previous year: $0.92

GAAP Operating Margin

Previous year: 21.6%

Non-GAAP Operating Margin

Previous year: 31.1%

Non-GAAP Income

Previous year: $180M

Cash and Equivalents

Previous year: $943M

Previous year: $6.99B

Loading...

BioMarin

Unlock previous datapoints

BioMarin

Unlock previous datapoints

BioMarin Revenue by Segment

Revenue by Segment

VOXZOGO Revenue

Unlock previous datapoints

CapyFin.com

VIMIZIM Revenue

Unlock previous datapoints

CapyFin.com

NAGLAZYME Revenue

Unlock previous datapoints

CapyFin.com

PALYNZIQ Revenue

Unlock previous datapoints

CapyFin.com

ALDURAZYME Revenue

Unlock previous datapoints

CapyFin.com

BRINEURA Revenue

Unlock previous datapoints

CapyFin.com

KUVAN Revenue

Unlock previous datapoints

CapyFin.com

ROCTAVIAN Revenue

CapyFin.com

Total Enzyme Therapies Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$10.7B

P/E Ratio

17.19

Sector

N/A

Industry

N/A

52-Week High

$70.6

52-Week Low

$51.4

GAAP Operating Margin

-5.1%

Non-GAAP Operating Margin

15.1%

Non-GAAP Income

$89M

GAAP Diluted Shares

192.23M

Operating Cash Flow

$100M